However, in pediatric IBD (PIBD) patients, only a few studies have shown a reduction of the serological response against the BNT162b2 mRNA vaccine in those treated with biologic therapy, especially anti-TNFα [14,15,16]. Here, TNF is linked to inflammatory bowel disease.